tiprankstipranks
Advertisement
Advertisement

LifeStance Health Guides 2026 Growth, Announces Buyback Program

Story Highlights
  • In 2025 LifeStance delivered double-digit revenue growth, achieved positive net income and significantly expanded Adjusted EBITDA and cash flow.
  • For 2026 LifeStance guided to further revenue and margin gains and authorized a $100 million share buyback, signaling confidence and enhanced capital returns.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
LifeStance Health Guides 2026 Growth, Announces Buyback Program

Claim 55% Off TipRanks

Lifestance Health Group ( (LFST) ) just unveiled an announcement.

On February 25, 2026, LifeStance Health Group reported that fourth-quarter 2025 revenue rose 17% year over year to $382.2 million and full-year revenue climbed 14% to $1.42 billion, driven by an expanded clinician base, higher visit volumes and improved productivity. The company swung to positive net income of $11.7 million in the quarter and $9.7 million for 2025, expanded Adjusted EBITDA by 49% in the quarter to $48.8 million, generated $146.2 million in operating cash flow for the year and ended 2025 with a solid cash position and moderate net debt.

Management issued 2026 guidance calling for further growth to $1.615 billion–$1.655 billion in revenue and higher Center Margin and Adjusted EBITDA, signaling confidence in continued operating leverage. The board also authorized a $100 million share repurchase program, underscoring LifeStance’s improved profitability and cash generation and suggesting a stronger capital return profile that could enhance shareholder value while the company continues to invest in long-term expansion.

The most recent analyst rating on (LFST) stock is a Buy with a $10.00 price target. To see the full list of analyst forecasts on Lifestance Health Group stock, see the LFST Stock Forecast page.

Spark’s Take on LFST Stock

According to Spark, TipRanks’ AI Analyst, LFST is a Neutral.

Lifestance Health Group’s overall score is driven by strong earnings call results and positive technical indicators. However, profitability challenges and a negative valuation score due to the high P/E ratio and lack of dividend yield weigh down the score.

To see Spark’s full report on LFST stock, click here.

More about Lifestance Health Group

LifeStance Health Group, Inc. is one of the largest U.S. providers of outpatient mental healthcare, offering in-person and virtual services through a nationwide network of clinicians. Founded in 2017 and listed on Nasdaq under the ticker LFST, the company focuses on expanding access to behavioral health services while scaling a multi-state clinical platform.

Average Trading Volume: 1,885,084

Technical Sentiment Signal: Buy

Current Market Cap: $2.78B

See more data about LFST stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1